FR165M - Nouveau médicament notamment pour le traitement des spasmes musculaires et bronchiques. - Google Patents

Nouveau médicament notamment pour le traitement des spasmes musculaires et bronchiques.

Info

Publication number
FR165M
FR165M FR835528A FR835528A FR165M FR 165 M FR165 M FR 165M FR 835528 A FR835528 A FR 835528A FR 835528 A FR835528 A FR 835528A FR 165 M FR165 M FR 165M
Authority
FR
France
Prior art keywords
muscle
treatment
new drug
bronchial spasms
spasms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR835528A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Francais de Chimiotherapie SA
Original Assignee
Laboratoires Francais de Chimiotherapie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Francais de Chimiotherapie SA filed Critical Laboratoires Francais de Chimiotherapie SA
Priority to FR835528A priority Critical patent/FR165M/fr
Application granted granted Critical
Publication of FR165M publication Critical patent/FR165M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/12—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/22—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
FR835528A 1960-05-10 1960-08-10 Nouveau médicament notamment pour le traitement des spasmes musculaires et bronchiques. Active FR165M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR835528A FR165M (fr) 1960-05-10 1960-08-10 Nouveau médicament notamment pour le traitement des spasmes musculaires et bronchiques.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR826778A FR1363859A (fr) 1960-05-10 1960-05-10 Nouveau dérivé de l'aconitine et procédé d'obtention
FR835528A FR165M (fr) 1960-05-10 1960-08-10 Nouveau médicament notamment pour le traitement des spasmes musculaires et bronchiques.

Publications (1)

Publication Number Publication Date
FR165M true FR165M (fr) 1961-02-13

Family

ID=8731096

Family Applications (2)

Application Number Title Priority Date Filing Date
FR826778A Expired FR1363859A (fr) 1960-05-10 1960-05-10 Nouveau dérivé de l'aconitine et procédé d'obtention
FR835528A Active FR165M (fr) 1960-05-10 1960-08-10 Nouveau médicament notamment pour le traitement des spasmes musculaires et bronchiques.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR826778A Expired FR1363859A (fr) 1960-05-10 1960-05-10 Nouveau dérivé de l'aconitine et procédé d'obtention

Country Status (1)

Country Link
FR (2) FR1363859A (fr)

Also Published As

Publication number Publication date
FR1363859A (fr) 1964-06-19

Similar Documents

Publication Publication Date Title
FR1444M (fr) Nouveau médicament notamment pour le traitement des irrégularités et des insuffisances ovariennes.
FR126M (fr) Nouveau médicament notamment pour le traitement de l'hyperlipémie post-prandiale ou chronique.
FR165M (fr) Nouveau médicament notamment pour le traitement des spasmes musculaires et bronchiques.
FR341M (fr) Nouveau médicament stéroide tétrahydroxylé notamment pour le traitement des spasmes d'origine coronaire.
FR1878M (fr) Nouveau polysaccharide, utilisable en thérapeutique, notamment pour le traitement des tumeurs solides.
FR363M (fr) Nouveau médicament pour le traitement des trypanosomoses, des salmonelloses et des infections pénicillo-résistantes.
FR151M (fr) Nouveau médicament notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
BE598672A (fr) Composition thérapeutique pour le traitement des affections hépatiques.
FR1489M (fr) Diphénlysulfones substituées en 4,4' et leurs préparations pharmaceutiques pour le traitement des maladies virales.
FR2413M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
FR1172M (fr) Nouveau médicament notamment pour le traitement des irrégularités et des insuffisances ovariennes.
FR385M (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
FR1412M (fr) Nouveau médicament notamment pour le traitement des bronchites, pneumonies, collapsus cardiaques et défaillances cardiaques.
FR133M (fr) Nouveau médicament dihydroxylé notamment pour le traitement des spasmes d'origine coronaire.
FR1204M (fr) Nouveau médicament, notamment pour le traitement de l'hyperlipémie chronique ou post-prandiale.
FR1407M (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine vasculaire.
FR1729M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
FR2510M (fr) Nouveau médicament utilisable pour le traitement des infections staphylococciques et analogues.
FR334M (fr) Nouveau médicament stéroide dinitré notamment pour le traitement des spasmes d'origine coronaire.
FR55M (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine coronaire
FR1783M (fr) Formes stabilisées des diméthylcarboxy-alkylsulfonium utilisées, notamment, pour le traitement des affections hépatiques et vasculaires.
FR33F (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
FR1731M (fr) Nouvel amino-pyrazole utilisable en thérapeutique, notamment comme médicament pour le traitement des affections inflammatoires.
FR1253788A (fr) Appareil pour le traitement des affections oto-rhino-laryngologiques, pulmonaires, etc.
FR36M (fr) Nouveau médicament notamment pour le traitement de l'hyperlipémie postprandiale ou aigue.